Serum calcium, magnesium and calcium magnesium ratio in women with preeclampsia
Not Applicable
- Conditions
- Health Condition 1: O149- Unspecified pre-eclampsia
- Registration Number
- CTRI/2021/05/033581
- Lead Sponsor
- Dr Priya S P Patil
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
For cases
Pregnant women with a gestational age of 20 weeks or more diagnosed with preeclampsia using the standard criteria including elevated blood pressure greater than or equal to SBP 140 and DBP 90 mm Hg with proteinuria greater than 1
For controls:
Normotensive participants without dipstick proteinuria matched for age, gestational, age, and parity.
Exclusion Criteria
1.Women with chronic hypertension
2.Multiple gestation pregnancy
3.Diabetic women
4.Woman with eclampsia
5.Woman with thyroid disease
6.Woman with autoimmune disease
7.Woman with renal disease
8.Woman with History of smoking or alcohol consumption
9.Woman on other drugs effecting blood pressure.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.The serum calcium magnesium ratio in preeclampsia and to compare it with normotensive pregnant woman using maternal serum anylates. <br/ ><br>2.Prevalence of hypomagnesemia and hypocalcemia among study participants <br/ ><br>3. The association between calcium- magnesium ratio and severity of pre-eclampsiaTimepoint: Serum calcium and magnesium levels will be assessed at the time of diagnosis of preeclampsia ( after 20 weeks ) and controls will be matched for the gestational age.
- Secondary Outcome Measures
Name Time Method eonatal OutcomesTimepoint: post delivery;Prevalence of hypomagnesemia and hypocalcemia among study participantsTimepoint: Serum calcium and magnesium levels will be assessed at the time of diagnosis of preeclampsia ( after 20 weeks ) and controls will be matched for the gestational age.